Autologous TILs Active in Refractory Melanoma

(MedPage Today) -- More than a third of patients with refractory advanced melanoma achieved durable responses to autologous tumor-infiltrating lymphocytes (TILs), according to a presentation at the American Society of Clinical Oncology (ASCO) virtual...